Your browser doesn't support javascript.
loading
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.
Epperla, Narendranath; Zhao, Qiuhong; Karmali, Reem; Torka, Pallawi; Shea, Lauren; Oh, Timothy S; Anampa-Guzmán, Andrea; Reves, Heather; Tavakkoli, Montreh; Greenwell, Irl Brian; Hansinger, Emily; Umyarova, Elvira; Annunzio, Kaitlin; Sawalha, Yazeed; Christian, Beth; Thomas, Colin; Barta, Stefan K; Geethakumari, Praveen Ramakrishnan; Bartlett, Nancy L; Grover, Natalie S; Olszewski, Adam J.
Affiliation
  • Epperla N; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Zhao Q; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Karmali R; Department of Medicine, Northwestern University, Chicago, IL.
  • Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.
  • Shea L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Oh TS; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Anampa-Guzmán A; Department of Medicine, Northwestern University, Chicago, IL.
  • Reves H; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.
  • Tavakkoli M; Department of Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
  • Greenwell IB; Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Hansinger E; Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
  • Umyarova E; Department of Medicine, Thomas Jefferson University, Philadelphia, PA.
  • Annunzio K; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Sawalha Y; Department of Medicine, University of Vermont, Burlington, VT.
  • Christian B; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Thomas C; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Barta SK; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Geethakumari PR; Department of Medicine, Thomas Jefferson University, Philadelphia, PA.
  • Bartlett NL; Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Grover NS; Department of Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
  • Olszewski AJ; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Blood Adv ; 7(17): 5038-5046, 2023 09 12.
Article in En | MEDLINE | ID: mdl-37315169
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: